Ravikirti, et al. “Evaluation of Ivermectin As a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 24, no. 3, July 2021, pp. 343-50, doi:10.18433/jpps32105.